4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001886794-26-000008
Chief Technical Ops Officer sold 17,000 shares at $55.00 ($935,068)
- Chief Technical Ops Officer acquired 17,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dhaliwal Harpreet S. Chief Technical Ops Officer | 2026-08-05 | Option exercise 10b5-1 | +17,000 | $24.79 | $421,430 | 93,756 | D: show line 1 in the form |
| Dhaliwal Harpreet S. Chief Technical Ops Officer | 2026-08-05 | Sale 10b5-1 | −17,000 | $55.00 | $935,068 | 76,756 | D: show line 2 in the form |
| Open-market sales · 17,000 sh · avg $55.00 · $935,068 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Dhaliwal Harpreet S. Chief Technical Ops Officer | 2026-08-05 | Option exercise · Stock Option (right to buy) 10b5-1 | −17,000 | 28,000 | D: show line 3 in the form |
Loading xslF345X06/wk-form4_1785970896.xml…